IGKV1D-22 and cancer: This study discovered novel PC-derived cachexigenic factors S100A8, S100A9, and S100A8/A9 heterodimer that potentially mediate muscle wasting, the hallmark of cancer cachexia, and thus have important prognostic and therapeutic implications.